|
1
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al: Global surveillance of cancer survival 1995–2009: Analysis
of individual data for 25,676,887 patients from 279
population-based registries in 67 countries (CONCORD-2). Lancet.
385:977–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kawazoe A, Shitara K, Fukuoka S, Kuboki Y,
Bando H, Okamoto W, Kojima T, Fuse N, Yamanaka T, Doi T, et al: A
retrospective observational study of clinicopathological features
of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with
metastatic colorectal cancer. BMC Cancer. 15:2582015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Didier DK, Schiffenbauer J, Woulfe SL,
Zacheis M and Schwartz BD: Characterization of the cDNA encoding a
protein binding to the major histocompatibility complex class II Y
box. Proc Natl Acad Sci USA. 85:7322–7326. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sakura H, Maekawa T, Imamoto F, Yasuda K
and Ishii S: Two human genes isolated by a novel method encode
DNA-binding proteins containing a common region of homology. Gene.
73:499–507. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lasham A, Print CG, Woolley AG, Dunn SE
and Braithwaite AW: YB-1: Oncoprotein, prognostic marker and
therapeutic target? Biochem J. 449:11–23. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo T, Yu Y, Yip GW, Baeg GH, Thike AA,
Lim TK, Tan PH, Matsumoto K and Bay BH: Y-box binding protein 1 is
correlated with lymph node metastasis in intestinal-type gastric
cancer. Histopathology. 66:491–499. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishio S, Ushijima K, Yamaguchi T,
Sasajima Y, Tsuda H, Kasamatsu T, Kage M, Ono M, Kuwano M and
Kamura T: Nuclear Y-box-binding protein-1 is a poor prognostic
marker and related to epidermal growth factor receptor in uterine
cervical cancer. Gynecol Oncol. 132:703–708. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kashihara M, Azuma K, Kawahara A, Basaki
Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K,
Aizawa H, et al: Nuclear Y-box binding protein-1, a predictive
marker of prognosis, is correlated with expression of HER2/ErbB2
and HER3/ErbB3 in non-small cell lung cancer. J Thorac Oncol.
4:1066–1074. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Janz M, Harbeck N, Dettmar P, Berger U,
Schmidt A, Jürchott K, Schmitt M and Royer HD: Y-box factor YB-1
predicts drug resistance and patient outcome in breast cancer
independent of clinically relevant tumor biologic factors HER2, uPA
and PAI-1. Int J Cancer. 97:278–282. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shiraiwa S, Kinugasa T, Kawahara A, Mizobe
T, Ohchi T, Yuge K, Fujino S, Katagiri M, Shimomura S, Tajiri K, et
al: Nuclear Y-box-binding protein-1 expression predicts poor
clinical outcome in stage III colorectal cancer. Anticancer Res.
36:3781–3788. 2016.PubMed/NCBI
|
|
11
|
Fujii T, Kawahara A, Basaki Y, Hattori S,
Nakashima K, Nakano K, Shirouzu K, Kohno K, Yanagawa T, Yamana H,
et al: Expression of HER2 and estrogen receptor alpha depends upon
nuclear localization of Y-box binding protein-1 in human breast
cancers. Cancer Res. 68:1504–1512. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan X, Yan L, Zhou J, Liu S, Shan Z, Jiang
C, Tian Y and Jin Z: High expression of Y-box-binding protein 1 is
associated with local recurrence and predicts poor outcome in
patients with colorectal cancer. Int J Clin Exp Pathol.
7:8715–8723. 2014.PubMed/NCBI
|
|
13
|
Zhang Y, Zhao PW, Feng G, Xie G, Wang AQ,
Yang YH, Wang D and Du XB: The expression level and prognostic
value of Y-box binding protein-1 in rectal cancer. PLoS One.
10:e01193852015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng Q, Huang S, Zhang A, Chen Q, Guo X,
Chen R and Yang T: Y-box protein 1 stimulates mesangial cell
proliferation via activation of ERK1/2. Nephron Exp Nephrol.
113:e16–e25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bergmann S, Royer-Pokora B, Fietze E,
Jürchott K, Hildebrandt B, Trost D, Leenders F, Claude JC, Theuring
F, Bargou R, et al: YB-1 provokes breast cancer through the
induction of chromosomal instability that emerges from mitotic
failure and centrosome amplification. Cancer Res. 65:4078–4087.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Basaki Y, Taguchi K, Izumi H, Murakami Y,
Kubo T, Hosoi F, Watari K, Nakano K, Kawaguchi H, Ohno S, et al:
Y-box binding protein-1 (YB-1) promotes cell cycle progression
through CDC6-dependent pathway in human cancer cells. Eur J Cancer.
46:954–965. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan XB, Zhu QC, Chen HQ, Peng JY, Chao HL,
Du HX, Wang ZG and Jin ZM: Knockdown of Y-box-binding protein-1
inhibits the malignant progression of HT-29 colorectal
adenocarcinoma cells by reversing epithelial-mesenchymal
transition. Mol Med Rep. 10:2720–2728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee C, Dhillon J, Wang MY, Gao Y, Hu K,
Park E, Astanehe A, Hung MC, Eirew P, Eaves CJ and Dunn SE:
Targeting YB-1 in HER-2 overexpressing breast cancer cells induces
apoptosis via the mTOR/STAT3 pathway and suppresses tumor growth in
mice. Cancer Res. 68:8661–8666. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shiota M, Yokomizo A, Itsumi M, Uchiumi T,
Tada Y, Song Y, Kashiwagi E, Masubuchi D and Naito S: Twist1 and
Y-box-binding protein-1 promote malignant potential in bladder
cancer cells. BJU Int. 108:E142–E149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang H, Sun R, Gu M, Li S, Zhang B, Chi Z
and Hao L: shRNA-mediated silencing of Y-box binding protein-1
(YB-1) suppresses growth of neuroblastoma cell SH-SY5Y in vitro and
in vivo. PLoS One. 10:e01272242015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hyogotani A, Ito K, Yoshida K, Izumi H,
Kohno K and Amano J: Association of nuclear YB-1 localization with
lung resistance-related protein and epidermal growth factor
receptor expression in lung cancer. Clin Lung Cancer. 13:375–384.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Lee C, Yokom D, Jiang H, Cheang MC,
Yorida E, Turbin D, Berquin IM, Mertens PR, Iftner T, et al:
Disruption of the Y-box binding protein-1 results in suppression of
the epidermal growth factor receptor and HER-2. Cancer Res.
66:4872–4879. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hynes NE and Lane HA: ERBB receptors and
cancer: The complexity of targeted inhibitors. Nat Rev Cancer.
5:341–354. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bonni A, Brunet A, West AE, Datta SR,
Takasu MA and Greenberg ME: Cell survival promoted by the Ras-MAPK
signaling pathway by transcription-dependent and -independent
mechanisms. Science. 286:1358–1362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sutherland BW, Kucab J, Wu J, Lee C,
Cheang MC, Yorida E, Turbin D, Dedhar S, Nelson C, Pollak M, et al:
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in
the cold shock domain and affects the anchorage-independent growth
of breast cancer cells. Oncogene. 24:4281–4292. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Basaki Y, Hosoi F, Oda Y, Fotovati A,
Maruyama Y, Oie S, Ono M, Izumi H, Kohno K, Sakai K, et al:
Akt-dependent nuclear localization of Y-box-binding protein 1 in
acquisition of malignant characteristics by human ovarian cancer
cells. Oncogene. 26:2736–2746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sinnberg T, Sauer B, Holm P, Spangler B,
Kuphal S, Bosserhoff A and Schittek B: MAPK and PI3K/AKT mediated
YB-1 activation promotes melanoma cell proliferation which is
counteracted by an autoregulatory loop. Exp Dermatol. 21:265–270.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chu PC, Lin PC, Wu HY, Lin KT, Wu C,
Bekaii-Saab T, Lin YJ, Lee CT, Lee JC and Chen CS: Mutant KRAS
promotes liver metastasis of colorectal cancer, in part, by
upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling
pathway. Oncogene. 37:3440–3455. 2018. View Article : Google Scholar : PubMed/NCBI
|
